Helping prevent cryptogenic stroke reoccurrence through the detection of asymptomatic A-Fib

Cryptogenic strokes are types of strokes without any clear cause¹. Multiple underlying factors can cause cryptogenic strokes, adding to the difficulty in performing an accurate diagnosis. A stroke occurs when the blood supply to the brain is interrupted, hence, heart rhythm and cardiac health are major risk factors. Vasculitis, endocarditis, or complications from asymptomatic atrial fibrillation (A-Fib)² are implicated in some cryptogenic strokes.

Approximately 1 in 3 ischemic strokes are cryptogenic³.
50% of strokes are embolic strokes of unknown source (ESUS)².
More A-Fib cases are caught the longer the patients are monitored^4,5.

Administering anticoagulation medication is effective at preventing recurring strokes when A-Fib is connected³. This means that catching A-Fib is crucial to knowing which treatment intervention is best at preventing stroke reoccurrence.

The CardiacSense watch is a certified medical device for continuous (24/7), non-invasive, real-time monitoring and detection of patients with A-Fib, with a sensitivity and specificity rate of above 95%⁶. The device contains a photoplethysmograph (PPG) and a one-lead electrocardiogram (ECG), giving it the ability to measure heart rate and heart rate variability constantly and accurately. In a comparison study, all A-Fib events detected by physicians based on Holter ECG were also detected by the CardiacSense watch⁵.

The CardiacSense watch provides accurate data for healthcare providers through the easy-to-access Physician portal, facilitating their diagnoses and treatment decisions.

References

[1] Understanding diagnosis and treatment of cryptogenic stroke: An updated health care professional guide. 2021. stroke.org/-/media/Stroke-Files/Cryptogenic-Professional-Resource-Files/Cryptogenic-Professional-Guide-ucm-477051.pdf

[2] Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017 Apr;48(4):867-872. doi: 10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6. PMID: 28265016.

[3] Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52:e364–e467.

[4] Aviram Hochstadt, Ehud Chorin, Sami Viskin, Arie Lorin Schwartz, Natan Lubman, Raphael Rosso, Continuous heart rate monitoring for automatic detection of atrial fibrillation with novel bio-sensing technology, Journal of Electrocardiology, Volume 52, 2019, Pages 23-27, ISSN 0022-0736, https://doi.org/10.1016/j.jelectrocard.2018.10.096.

[5] Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478-2486.

[6] CardiacSense, A Prospective, Open, Multi-Center, Controlled Study to Evaluate the Safety, Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation, 2020

Wearing the CardiacSense watch can help healthcare practitioners make the right decisions to prevent reoccurrence of strokes linked to asymptomatic A-fib.

Reach out to find out more: